Osamu Ishimoto

Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial

Toshiaki Takahashi, Takeharu Yamanaka, Takashi Seto et al. · The Lancet Oncology · 2017 · 515 citations

Radiation Medicine, Radiation Therapy, Medicine +6

Randomized Phase II Trial Comparing Amrubicin With Topotecan in Patients With Previously Treated Small-Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 0402

Akira Inoue, Shunichi Sugawara, Koichi Yamazaki et al. · Journal of Clinical Oncology · 2008 · 233 citations

Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73.

Osamu Ishimoto, Chikashi Kawahara, Kentaro Enjo et al. · PubMed · 2002 · 177 citations

Engineering, Genetics, Human Polymorphism +19

Granulocyte-Macrophage Colony–Stimulating Factor and Lung Immunity in Pulmonary Alveolar Proteinosis

Ryushi Tazawa, Emi Hamano, Toru Arai et al. · American Journal of Respiratory and Critical Care Medicine · 2005 · 120 citations

Prophylactic cranial irradiation (PCI) has a detrimental effect on the overall survival (OS) of patients (pts) with extensive disease small cell lung cancer (ED-SCLC): Results of a Japanese randomized phase III trial.

Takashi Seto, Toshiaki Takahashi, Takeharu Yamanaka et al. · Journal of Clinical Oncology · 2014 · 54 citations

Detrimental Effect, High-grade Gliomas, Metronomic Chemotherapy +21